| Victoria Hale | |
| Workplaces: | Food and Drug Administration (United States) |
| Alma Mater: | University of California, San Francisco |
| Thesis1 Title: | and |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Awards: | MacArthur Fellow |
| Spouses: | )--> |
| Partners: | )--> |
Victoria Hale founded the nonprofit pharmaceutical company The Institute for OneWorld Health in San Francisco, California in 2000[1] and was its chairman and CEO until 2008, when she became Chair Emeritus. She then went on to found Medicines360, a nonprofit pharmaceutical company dedicated to developing medicines for women and children, including pregnant women.
Hale earned her B.S. in pharmacy from the University of Maryland in 1983 and her Ph.D. in pharmaceutical chemistry from the UCSF School of Pharmacy in 1990.[2] She is an Adjunct Associate professor in Biopharmaceutical Sciences at UCSF, and an advisor to the World Health Organization (WHO).
Her past affiliations include the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, and Genentech.[3]